Abstract:Congenital heart disease (CHD) is the most prevalent type of birth defect in humans and is the leading non-infectious cause of infant death worldwide. There is a growing body of evidence demonstrating that genetic defects play an important role in the pathogenesis of CHD. However, CHD is a genetically heterogeneous disease and the genetic basis underpinning CHD in an overwhelming majority of patients remains unclear. In this study, the coding exons and splice junction sites of the TBX1 gene, which encodes a T-box homeodomain transcription factor essential for proper cardiovascular morphogenesis, were sequenced in 230 unrelated children with CHD. The available family members of the index patient carrying an identified mutation and 200 unrelated ethnically matched healthy individuals used as controls were subsequently genotyped for TBX1. The functional effect of the TBX1 mutation was predicted by online program MutationTaster and characterized by using a dual-luciferase reporter assay system. As a result, a novel heterozygous TBX1 mutation, p.Q277X, was identified in an index patient with double outlet right ventricle (DORV) and ventricular septal defect (VSD). Genetic analysis of the proband's available relatives showed that the mutation co-segregated with CHD transmitted in an autosomal dominant pattern with complete penetrance. The nonsense mutation, which was absent in 400 control chromosomes, altered the amino acid that was completely conserved evolutionarily across species and was predicted to be disease-causing by MutationTaster. Biochemical analysis revealed that Q277X-mutant TBX1 lost transcriptional activating function when compared with its wild-type counterpart. This study firstly associates TBX1 loss-of-function mutation with enhanced susceptibility to DORV and VSD in humans, which provides novel insight into the molecular mechanism underlying CHD and suggests potential implications for the development of new preventive and therapeutic strategies for CHD.

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

Identification and Functional Validation of Variants in the Promoter Region of HAND1 Gene in Sporadic Tetralogy of Fallot

A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis

Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot.

Gata5 Loss-Of-Function Mutations Underlie Tetralogy Of Fallot

TBX20 Loss-of-function Mutation Responsible for Familial Tetralogy of Fallot or Sporadic Persistent Truncus Arteriosus.

PCR-sequenced under an ABI PRISM 3130 XL DNA Analyzer ( Applied Biosystems ) with BigDye ® Terminator v 3 . 1 Cycle

Somatic Gata5 Mutations In Sporadic Tetralogy Of Fallot

PITX2 Loss-of-function Mutation Contributes to Tetralogy of Fallot

Somatic GATA4 mutation contributes to tetralogy of Fallot

GATA4 loss-of-function mutations underlie familial tetralogy of fallot.

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

HAND1 Loss-of-function Mutation Contributes to Congenital Double Outlet Right Ventricle.

Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot

Somatic Mutations in the GATA6 Gene Underlie Sporadic Tetralogy of Fallot

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

HAND2 Loss-of-function Mutation Causes Familial Dilated Cardiomyopathy.

Tetralogy of Fallot: Variants of MYH6 Gene Promoter and Cellular Functional Analyses